Ray Mastriani

Senior Director Of Scientific Engagement And Portfolio Development at Esperion Therapeutics

Ray Mastriani has a diverse work experience starting from 2002 as a Clinical Pharmacist at the Department of Veterans Affairs. Ray then worked at AstraZeneca as a Senior Regional Scientific Manager from 2006 to 2012. From 2012 to 2017, they served as a Senior Medical Science Liaison at Actelion. Ray then transitioned to Akcea Therapeutics where they worked as a Field Medical Director from 2017 to 2018. In 2019, they joined Pfizer as a Field Medical Director and later that year moved to Esperion where they held various positions including Executive Medical Science Liaison and Regional Director. Currently, they are the Senior Director of Scientific Engagement and Portfolio Development at Esperion.

Ray Mastriani has a diverse and extensive education history. In 1987, they began their higher education journey with pre-pharmacy studies at Western New England University, where they completed their studies in 1990. Ray then pursued a B.S. in Pharmacy at Massachusetts College of Pharmacy and Health Sciences from 1990 to 1992.

Following their undergraduate studies, Ray attended the University of Rhode Island from 1999 to 2003, where they obtained a Doctor of Pharmacy (PharmD) degree and focused on the field of pharmacy.

In 2010, Ray enrolled in the D'Amore-McKim School of Business at Northeastern University and completed their Master of Business Administration (M.B.A.) degree in 2012. The field of study for their MBA is not specified.

Continuing their commitment to lifelong learning, Ray pursued additional courses and certifications to expand their expertise. In 2015, they participated in the Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation at Tufts University. In 2016, Ray completed the Advanced Academic Programs in Biotechnology Enterprise and Entrepreneurship at The Johns Hopkins University.

In 2019, Ray attended the altMBA program to enhance their knowledge in entrepreneurship and innovation. Lastly, in 2022, they completed the Program on Negotiation at Harvard Law School, focusing on negotiation skills. Ray also obtained two certifications from Harvard Law School: "Negotiation and Leadership" in June 2022, and "Unlocking Value in Complex Business Deals" in June 2020.

Aside from their educational achievements, Ray holds the certification of Registered Pharmacist from the Commonwealth of Massachusetts, although the specific details of when they obtained this certification are not provided.

Links

Previous companies

AstraZeneca logo
Pfizer logo

Org chart

Peers

Timeline

  • Senior Director Of Scientific Engagement And Portfolio Development

    December, 2022 - present

  • Medical Director

    October, 2021

  • Executive Medical Science Liaison

    March, 2021

  • Regional Director CV MSL North Team

    December, 2019

View in org chart